Targeting of specific signalling pathways, such as the Nrf2/Kelch ECH associating protein 1 (Keap1) signalling pathway, can provide innovative approaches to tackle oxidative stress, and consequently, its related diseases, which include cardiovascular and pulmonary diseases, diabetes, cancers, and neurodegenerative disorders. The gene discussed is KEAP1; the disease is cancer.